All Stories

  1. An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity

    Article • Arthritis & Rheumatology, August 2018, Wiley

    dr Marjan M Ghiti Moghadam

  2. Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open-Label Randomized Controlled Trial

    Article • Arthritis & Rheumatology, July 2016, Wiley

    dr Marjan M Ghiti Moghadam